Jérôme Galon

68.8k total citations · 15 hit papers
239 papers, 39.6k citations indexed

About

Jérôme Galon is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jérôme Galon has authored 239 papers receiving a total of 39.6k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Oncology, 125 papers in Immunology and 46 papers in Molecular Biology. Recurrent topics in Jérôme Galon's work include Cancer Immunotherapy and Biomarkers (139 papers), Immunotherapy and Immune Responses (81 papers) and Colorectal Cancer Treatments and Studies (46 papers). Jérôme Galon is often cited by papers focused on Cancer Immunotherapy and Biomarkers (139 papers), Immunotherapy and Immune Responses (81 papers) and Colorectal Cancer Treatments and Studies (46 papers). Jérôme Galon collaborates with scholars based in France, United States and Belgium. Jérôme Galon's co-authors include Wolf H. Fridman, Franck Pagès, Bernhard Mlecnik, Daniela Bruni, Gabriela Bindea, Catherine Sautès‐Fridman, Amos Kirilovsky, Zlatko Trajanoski, Marie Tosolini and Helen K. Angell and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jérôme Galon

229 papers receiving 39.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

2006 4.8k citations Jérôme Galon, Anne Costes et al. profile →
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

2009 4.6k citations Gabriela Bindea, Bernhard Mlecnik et al. profile →
The immune contexture in human tumours: impact on clinical outcome

2012 3.5k citations Wolf H. Fridman, Franck Pagès et al. profile →
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

2013 2.9k citations Gabriela Bindea, Bernhard Mlecnik et al. profile →
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

2019 2.3k citations Jérôme Galon, Daniela Bruni Nature Reviews Drug Discovery profile →
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer

2005 1.6k citations Franck Pagès, Anne Berger et al. profile →
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

2020 1.0k citations Daniela Bruni, Helen K. Angell et al. profile →
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

2011 877 citations Marie Tosolini, Amos Kirilovsky et al. Cancer Research profile →
CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data

2013 831 citations Gabriela Bindea, Jérôme Galon et al. profile →
Immune infiltration in human tumors: a prognostic factor that should not be ignored

2009 805 citations Franck Pagès, Jérôme Galon et al. profile →
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction

2011 765 citations Bernhard Mlecnik, Marie Tosolini et al. profile →
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

2009 724 citations Franck Pagès, Amos Kirilovsky et al. profile →
The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures

2013 620 citations Jérôme Galon, Helen K. Angell et al. profile →
From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer

2013 418 citations Helen K. Angell, Jérôme Galon profile →
Tumor Immunology and Tumor Evolution: Intertwined Histories

2020 377 citations Jérôme Galon, Daniela Bruni profile →

Peers

Countries citing papers authored by Jérôme Galon

Since Specialization

Citations

This map shows the geographic impact of Jérôme Galon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Galon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Galon more than expected).

Fields of papers citing papers by Jérôme Galon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Galon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Galon. The network helps show where Jérôme Galon may publish in the future.

Co-authorship network of co-authors of Jérôme Galon

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Galon. A scholar is included among the top collaborators of Jérôme Galon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Galon. Jérôme Galon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Facts and Hopes: CAR T-Cell Therapy and Immune Contexture in Non-Hodgkin Lymphoma 2025 ·Clinical Cancer Research ·(unknown), Frederick L. Locke, Nathalie Scholler, Mike Mattie, Simone Filosto, Davide Bedognetti, Jérôme Galon	0
2	Partial transvenous embolization as an intermediate strategy for large brain arteriovenous malformations: A technical note 2025 ·Journal of NeuroInterventional Surgery ·(unknown), (unknown), Christina Iosif, Jérôme Galon, (unknown), Suzana Saleme, Aymeric Rouchaud, Charbel Mounayer	0
3	Abstract LB346: Dynamic changes in the tumor microenvironment from initial diagnosis through sequential therapies in patients with large B cell lymphoma undergoing axicabtagene ciloleucel (axi-cel) treatment 2024 ·Cancer Research ·Michael Mattie, (unknown), Aurélie Auguste, (unknown), Jenny Kim, Christina To, (unknown), Simone Filosto, Rhine R. Shen, Jérôme Galon	1
4	Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma 2023 ·Cancer Research Communications ·Maria Secrier, Lara McGrath, Felicia Ng, Sakshi Gulati, Amelia Raymond, Barrett Nuttall, (unknown), Emma V. Jones, Ben S. Sidders, Jérôme Galon, J. Carl Barrett, Helen K. Angell	7
5	Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response 2022 ·Cancers ·Bernardo L. Rapoport, Simon Nayler, Bernhard Mlecnik, Teresa Smit, (unknown), (unknown), (unknown), Jérôme Galon, Carol‐Ann Benn, Ronald Anderson	18
6	Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy) 2021 ·Journal of Translational Medicine ·Paolo A. Ascierto, Carlo Bifulco, Fortunato Ciardiello, Sandra Demaria, Leisha A. Emens, Robert L. Ferris, Silvia C. Formenti, Jérôme Galon, Samir N. Khleif, Tomas Kirchhoff, Jennifer L. McQuade, Kunle Odunsi, Akash Patnaik, Chrystal M. Paulos, Janis M. Taube, John M. Timmerman, Bernard A. Fox, Patrick Hwu, Igor Puzanov	3
7	No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study 2020 ·OncoImmunology ·Paolo A. Ascierto, Francesco M. Marincola, Bernard A. Fox, Jérôme Galon	11
8	Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer 2020 ·Cancers ·Alessandro Ottaiano, Michele Caraglia, Annabella Di Mauro, Gerardo Botti, Angela Lombardi, Jérôme Galon, Amalia Luce, (unknown), Francesco Perri, Mariachiara Santorsola, Fabienne Hermitte, Giovanni Savarese, Fabiana Tatangelo, Vincenza Granata, Francesco Izzo, Andrea Belli, Stefania Scala, Paolo Delrio, Luisa Circelli, Guglielmo Nasti	24
9	Approaches to treat immune hot, altered and cold tumours with combination immunotherapies breakdown → 2019 ·Nature Reviews Drug Discovery ·Jérôme Galon, Daniela Bruni	2343
10	Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy) 2018 ·Journal for ImmunoTherapy of Cancer ·Paolo A. Ascierto, James Brugarolas, Luigi Buonaguro, Lisa H. Butterfield, David P. Carbone, Bruno Daniele, Robert L. Ferris, Bernard A. Fox, Jérôme Galon, Cesare Gridelli, Howard L. Kaufman, Christopher A. Klebanoff, Ignacio Melero, Paul Nathan, Chrystal M. Paulos, Marco Ruella, Ryan J. Sullivan, Hassane M. Zarour, Igor Puzanov	9
11	Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy 2015 ·Genome Biology ·Mihaela Angelova, Pornpimol Charoentong, Hubert Hackl, M. Fischer, René Snajder, Anne Krogsdam, Maximilian J. Waldner, Gabriela Bindea, Bernhard Mlecnik, Jérôme Galon, Zlatko Trajanoski	387
12	From mice to humans: developments in cancer immunoediting 2015 ·Journal of Clinical Investigation ·Michele W.L. Teng, Jérôme Galon, Wolf H. Fridman, Mark J. Smyth	244
13	Trial watch: Naked and vectored DNA-based anticancer vaccines 2015 ·OncoImmunology ·Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès‐Fridman, Jitka Fučíková, Jérôme Galon, Radek Špíšek, Éric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi	32
14	Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer 2014 ·Clinical Cancer Research ·Maria-Gabriela Aniței, Guy Zeitoun, Bernhard Mlecnik, Florence Marliot, Nacilla Haicheur, (unknown), Amos Kirilovsky, Christine Lagorce, Gabriela Bindea, Dan Ferariu, Mihai Danciu, Patrick Bruneval, Viorel Scripcariu, Jean‐Marc Chevallier, Franck Zinzindohoué, Anne Berger, Jérôme Galon, Franck Pagès	282
15	Trial Watch: Radioimmunotherapy for oncological indications 2014 ·OncoImmunology ·Norma Bloy, Jonathan Pol, Gwenola Manic, Ilio Vitale, Alexander Eggermont, Jérôme Galon, Éric Tartour, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi	47
16	Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer breakdown → 2011 ·Cancer Research ·Marie Tosolini, Amos Kirilovsky, Bernhard Mlecnik, Tessa Fredriksen, (unknown), Gabriela Bindea, Anne Berger, Patrick Bruneval, Wolf H. Fridman, Franck Pagès, Jérôme Galon	877
17	Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence 2009 ·Cancer Research ·Matthieu Camus, Marie Tosolini, Bernhard Mlecnik, Franck Pagès, Amos Kirilovsky, Anne Berger, Anne Costes, Gabriela Bindea, Pornpimol Charoentong, Patrick Bruneval, Zlatko Trajanoski, Wolf H. Fridman, Jérôme Galon	226
18	Implications immunologiques potentielles du curage ganglionnaire : Exemple du cancer colorectal 2008 ·Journal de Chirurgie ·(unknown), (unknown), (unknown), (unknown), Jérôme Galon, Wolf H. Fridman	1
19	Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells 2002 ·Journal of Clinical Investigation ·Lydie Cassard, Joël F.G. Cohen-Solal, Annie Galinha, Xavier Sastre‐Garau, Claire Mathiot, Jérôme Galon, Thierry Dorval, Alain Bernheim, Wolf H. Fridman, Catherine Sautès‐Fridman	25
20	A New Set of Monoclonal Antibodies Against Human FcγRII (CD32) and FcγRIII (CD16): Characterization and Use in Various Assays 1997 ·Hybridoma ·Frédéric Vely, Nadège Gruel, Janine Moncuit, Olivier Cochet‐Escartin, Hélène Rouard, (unknown), Jérôme Galon, Catherine Sautès‐Fridman, Wolf H. Fridman, Jean‐Luc Teillaud	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact